MPG, HIV related
CAS No. 395069-92-8
MPG, HIV related( —— )
Catalog No. M30441 CAS No. 395069-92-8
MPG, HIV related is 27-aa peptide, derived from both the nuclear localisation sequence of SV40 large T antigen and the fusion peptide domain of HIV-1 gp41 and is a potent delivery agent for the generalised delivery of nucleic acids and of oligonucleotides into cultured cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 482 | Get Quote |
|
| 10MG | 705 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMPG, HIV related
-
NoteResearch use only, not for human use.
-
Brief DescriptionMPG, HIV related is 27-aa peptide, derived from both the nuclear localisation sequence of SV40 large T antigen and the fusion peptide domain of HIV-1 gp41 and is a potent delivery agent for the generalised delivery of nucleic acids and of oligonucleotides into cultured cells.
-
DescriptionMPG, HIV related is 27-aa peptide, derived from both the nuclear localisation sequence of SV40 large T antigen and the fusion peptide domain of HIV-1 gp41 and is a potent delivery agent for the generalised delivery of nucleic acids and of oligonucleotides into cultured cells.(In Vitro):MPG, HIV related is 27-aa peptide vector, derived from both the nuclear localisation sequence of SV40 large T antigen and the fusion peptide domain of HIV-1 gp41 and is a potent delivery agent for the generalised delivery of nucleic acids and of oligonucleotides into cultured cells and for gene therapy. MPG enables complete expression of the gene produces encoded by the plasmids it delivers into cultured cell.
-
In VitroMPG, HIV related is 27-aa peptide vector, derived from both the nuclear localisation sequence of SV40 large T antigen and the fusion peptide domain of HIV-1 gp41 and is a potent delivery agent for the generalised delivery of nucleic acids and of oligonucleotides into cultured cells and for gene therapy. MPG enables complete expression of the gene produces encoded by the plasmids it delivers into cultured cell.
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHIV
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number395069-92-8
-
Formula Weight2766.22
-
Molecular FormulaC126H201N35O33S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:Gly-Ala-Leu-Phe-Leu-Gly-Phe-Leu-Gly-Ala-Ala-Gly-Ser-Thr-Met-Gly-Ala-Trp-Ser-Gln-Pro-Lys-Ser-Lys-Arg-Lys-Val
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Morris MC, et al. A novel potent strategy for gene delivery using a single peptide vector as a carrier. Nucleic Acids Res. 1999 Sep 1;27(17):3510-7.
molnova catalog
related products
-
TERT-IN-1
TERT-IN-1 has anti-HIV activity and can be used to study HIV infection.
-
ST7612AA1
ST7612AA1 is a novel potent and oral HDCA inhibitor that acts as an HIV-1 latency reactivator. ST7612AA1 showed significant antitumor activity at low concentrations in vitro and in vivo.
-
N.41
N.41 (HIV inhibitor N.41, Vif inhibitor N.41) is a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G (A3G) protein (IC50=2.2 uM).
Cart
sales@molnova.com